Cancer Predisposition Risk Assessment System

FDA classification

FDA Class 2 ·Cancer Predisposition Risk Assessment System

Cytokeratins

FDA classification

FDA Class 2 ·Cytokeratins

Early Growth Response Gene 1 (Egr1) Fish Probe Kit For Specimen Characterization

FDA classification

FDA Class 2 ·Early Growth Response Gene 1 (Egr1) Fish Probe Kit For Specimen Characterization

System, Cystic Fibrosis Transmembrane Conductance Regulator Gene, Mutations & Variants Panel Sequencing Detection

FDA classification

FDA Class 2 ·System, Cystic Fibrosis Transmembrane Conductance Regulator Gene, Mutations & Variants Panel Sequencing Detection

System, Blood Collection, Rna Stabilization, Rna Purification, Rt-Pcr Molecular Diagnostic Test

FDA classification

FDA Class 2 ·System, Blood Collection, Rna Stabilization, Rna Purification, Rt-Pcr Molecular Diagnostic Test

Igd, Peroxidase, Antigen, Antiserum, Control

FDA classification

FDA Class 2 ·Igd, Peroxidase, Antigen, Antiserum, Control

Whole Exome Sequencing Constituent Device

FDA classification

FDA Class 2 ·Whole Exome Sequencing Constituent Device

Dna-Probe Kit, Human Chromosome

FDA classification

FDA Class 2 ·Dna-Probe Kit, Human Chromosome

System, Cystic Fibrosis Transmembrane Conductance Regulator Gene, Variant Gene Sequence Detection

FDA classification

FDA Class 2 ·System, Cystic Fibrosis Transmembrane Conductance Regulator Gene, Variant Gene Sequence Detection

Early Growth Response 1 (Egr) Fish Probe Kit

FDA classification

FDA Class 2 ·Early Growth Response 1 (Egr) Fish Probe Kit

Microscope, Automated, Image Analysis, Immunohistochemistry,Operator Intervention,Nuclear Intensity & Percent Positivity

FDA classification

FDA Class 2 ·Microscope, Automated, Image Analysis, Immunohistochemistry,Operator Intervention,Nuclear Intensity & Percent Positivity

Prostate-Specific Antigen (Psa) For Prognostic, Recurrence Risk Assessment Of Prostate Cancers

FDA classification

FDA Class 2 ·Prostate-Specific Antigen (Psa) For Prognostic, Recurrence Risk Assessment Of Prostate Cancers

Lynch Syndrome Test System

FDA classification

FDA Class 2 ·Lynch Syndrome Test System

Dna-Probe Kit, Human Chromosome X And Y, Bmt Engraftment

FDA classification

FDA Class 2 ·Dna-Probe Kit, Human Chromosome X And Y, Bmt Engraftment

Immunohistochemistry Antibody Assay, Estrogen Receptor

FDA classification

FDA Class 2 ·Immunohistochemistry Antibody Assay, Estrogen Receptor

Automated Digital Image Manual Interpretation Microscope

FDA classification

FDA Class 2 ·Automated Digital Image Manual Interpretation Microscope

Quality Control For Molecular Immunohematology Tests

FDA classification

FDA Class 2 ·Quality Control For Molecular Immunohematology Tests

Test, Factor Ii G20210a Mutations, Genomic Dna Pcr

FDA classification

FDA Class 2 ·Test, Factor Ii G20210a Mutations, Genomic Dna Pcr

Test, Factor V Leiden Mutations, Genomic Dna Pcr

FDA classification

FDA Class 2 ·Test, Factor V Leiden Mutations, Genomic Dna Pcr

Analyzer, Chromosome, Automated

FDA classification

FDA Class 2 ·Analyzer, Chromosome, Automated